Other antigens tested in glioblastoma models, most of which have already made it into clinical testing as below, include EphA2, B7-H3, CD133, CD70, GD2, NKG2D, Fn14, and podoplanin (Table 1). Here, KLRK1 is linked to glioblastoma.